Ion Channel-Targeted Drug Development Summit

The Ion Channel-Targeted Drug Development Summit is an industry-led, modality- and indication-agnostic meeting organized by Hanson Wade. Held in Boston, MA from September 23–24, 2026, the event convenes leading biopharma and academic experts to explore advances in discovery, translational science, and clinical development. Distinctive for its focus on overcoming historical challenges like subtype selectivity, safety, and translatability, the summit features data-led presentations and interactive discussions spanning automated electrophysiology, structural biology, and emerging therapeutic modalities.